A Message From Your Friends At The Southeast AETC: Our hearts go out to those in our community who were affected by the hurricanes. If you have patients that are having trouble accessing HIV services during this time, we urge you to utilize HRSA’s Find a Ryan White Provider tool to help navigate them to services nearby.

Webinar: HIV/HCV Coinfection: Why It Matters and What To Do About It

Primary Care & Comorbidities, Webcast

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides

Facilitated by Cody A. Chastain, MD
October 26, 2016

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides

Facilitated by Cody A. Chastain, MD
October 26, 2016

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides